Autolus Therapeutics PLC (AUTL)
2.84
+0.04
(+1.43%)
USD |
NASDAQ |
Nov 21, 16:00
2.87
+0.03
(+1.06%)
Pre-Market: 09:22
Autolus Therapeutics Total Liabilities (Quarterly): 350.52M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 350.52M |
| June 30, 2024 | 325.78M |
| March 31, 2024 | 319.41M |
| December 31, 2023 | 263.91M |
| September 30, 2023 | 225.58M |
| June 30, 2023 | 221.66M |
| March 31, 2023 | 193.05M |
| December 31, 2022 | 191.60M |
| September 30, 2022 | 102.68M |
| June 30, 2022 | 99.46M |
| March 31, 2022 | 92.85M |
| December 31, 2021 | 92.24M |
| Date | Value |
|---|---|
| September 30, 2021 | 51.91M |
| June 30, 2021 | 46.97M |
| March 31, 2021 | 50.18M |
| December 31, 2020 | 84.20M |
| September 30, 2020 | 80.27M |
| June 30, 2020 | 51.60M |
| March 31, 2020 | 50.19M |
| December 31, 2019 | 48.69M |
| September 30, 2019 | 45.00M |
| June 30, 2019 | 47.92M |
| March 31, 2019 | 46.47M |
| March 31, 2018 | 16.36M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
46.97M
Minimum
Jun 2021
350.52M
Maximum
Sep 2024
147.14M
Average
96.15M
Median
Total Liabilities (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 237.45M |
| Biodexa Pharmaceuticals PLC | 6.628M |
| NuCana PLC | 20.58M |
| TC BioPharm (Holdings) PLC | 7.807M |
| Bicycle Therapeutics PLC | 165.71M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 827.49M |
| Shareholders Equity (Quarterly) | 476.96M |